About Concord Medical Services (NYSE:CCM)
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company's segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China. Its network consists of approximately 130 cooperative centers based in over 70 hospitals, spanning approximately 60 cities across 25 provinces and administrative regions in China. Its network includes approximately 60 radiotherapy centers and over 60 diagnostic imaging centers and approximately seven centers. The Company's cooperative centers are equipped with a primary unit of medical equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, positron emission tomography-computed tomography (PET-CT) scanner or magnetic resonance imaging (MRI) scanner.
Industry, Sector and Symbol
Industry Healthcare Facilities & Services
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Annual Sales$65.54 million
Price / Sales2.25
Price / CashN/A
Book Value$4.09 per share
Price / Book0.83
Return on EquityN/A
Return on AssetsN/A
Concord Medical Services (NYSE:CCM) Frequently Asked Questions
What is Concord Medical Services' stock symbol?
Concord Medical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "CCM."
How were Concord Medical Services' earnings last quarter?
Concord Medical Services Holdings Limited (NYSE:CCM) released its earnings results on Wednesday, August, 24th. The company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of $0.21 by $0.27. The business earned $18.93 million during the quarter. View Concord Medical Services' Earnings History.
Who are some of Concord Medical Services' key competitors?
Some companies that are related to Concord Medical Services include Calithera Biosciences (CALA), Innate Pharma (IPHYF), Antares Pharma (ATRS), Utah Medical Products (UTMD), Tetraphase Pharmaceuticals (TTPH), NewLink Genetics (NLNK), Bellicum Pharmaceuticals (BLCM), ChemoCentryx (CCXI), Kadmon (KDMN), Ardelyx (ARDX), Allena Pharmaceuticals (ALNA), Helius Medical Technologies (HSDT), Merus (MRUS), Enzymotec (ENZY), Sientra (SIEN), XOMA (XOMA), GTX (GTXI) and Arbutus Biopharma (ABUS).
Who are Concord Medical Services' key executives?
Concord Medical Services' management team includes the folowing people:
- Jianyu Yang, Chairman of the Board, Chief Executive Officer (Age 42)
- Zheng Cheng, President, Chief Operating Officer, Director (Age 48)
- Yaw Kong Yap, Chief Financial Officer (Age 48)
- Jing Zhang, Chief Administrative Officer (Age 48)
- Jigang Sun, Chief Investment Officer (Age 45)
- Shang-yan Chuang, Director
- Zhang Liping, Independent Director
- Weibo Yin, Independent Director (Age 81)
- Elaine Zong, Independent Director (Age 41)
- Ting Bun Lee CPA, Independent Non-Executive Director (Age 49)
Who owns Concord Medical Services stock?
How do I buy Concord Medical Services stock?
Shares of Concord Medical Services can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Concord Medical Services' stock price today?
One share of Concord Medical Services stock can currently be purchased for approximately $3.40.
How big of a company is Concord Medical Services?
Concord Medical Services has a market capitalization of $157.41 million and generates $65.54 million in revenue each year. Concord Medical Services employs 739 workers across the globe.
How can I contact Concord Medical Services?
Concord Medical Services' mailing address is 18/F TOWER A GLOBAL TRADE CENTER 36 NORTH THIRD RING ROAD DONGCHENG DISTRICT, BEIJING F4, 100013. The company can be reached via phone at 86-10-5903-6688 or via email at [email protected]
MarketBeat Community Rating for Concord Medical Services (CCM)MarketBeat's community ratings are surveys of what our community members think about Concord Medical Services and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Concord Medical Services (NYSE:CCM) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Concord Medical Services (NYSE:CCM) Earnings History and Estimates Chart
Concord Medical Services (NYSE CCM) Earnings History by Quarter
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/21/2013||Q1 2013||$0.07||$35.80 million||$32.80 million||View||Listen|
Concord Medical Services (NYSE:CCM) Earnings Estimates
Current Year EPS Consensus Estimate: $-0.25 EPS
Next Year EPS Consensus Estimate: $0.07 EPS
Concord Medical Services (NYSE:CCM) Dividend Information
|Most Recent Dividend:||1/30/2016|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||0.00% (Based on This Year's Estimates)|
0.00% (Based on Next Year's Estimates)
Concord Medical Services (NYSE:CCM) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading History for Concord Medical Services (NYSE CCM)
No insider trades for this company have been tracked by MarketBeat.com
Concord Medical Services (NYSE CCM) News Headlines
Concord Medical Services (NYSE:CCM) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Concord Medical Services (NYSE:CCM) Income Statement, Balance Sheet and Cash Flow Statement
Concord Medical Services (NYSE CCM) Stock Chart for Friday, December, 15, 2017